Cargando…

Expression of Ripk1 and DAM genes correlates with severity and progression of Krabbe disease

Krabbe disease, an inherited leukodystrophy, is a sphingolipidosis caused by deficiency of β-galactocerebrosidase: it is characterized by myelin loss, and pathological activation of macrophage/microglia and astrocytes. To define driving pathogenic factors, we explored the expression repertoire of ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cachón-González, María B, Wang, Susan, Cox, Timothy M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	General Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561423/ https://www.ncbi.nlm.nih.gov/pubmed/34172992 http://dx.doi.org/10.1093/hmg/ddab159

Ejemplares similares

Upregulation of non-canonical and canonical inflammasome genes associates with pathological features in Krabbe disease and related disorders
por: Cachón-González, María B, et al.
Publicado: (2022)

Gene therapy for CNS diseases – Krabbe disease
por: Rafi, Mohammad A.
Publicado: (2016)

Neuroimmune mechanisms in Krabbe's disease
por: Potter, Gregory B., et al.
Publicado: (2016)

Efficacy and Safety of a Krabbe Disease Gene Therapy
por: Hordeaux, Juliette, et al.
Publicado: (2022)

Advances in the Diagnosis and Treatment of Krabbe Disease
por: Wenger, David A, et al.
Publicado: (2021)

Krabbe disease: New hope for an old disease
por: Bradbury, Allison M., et al.
Publicado: (2021)

Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months
por: Beltran-Quintero, Maria L., et al.
Publicado: (2019)

Azasugar inhibitors as pharmacological chaperones for Krabbe disease
por: Hill, Chris H., et al.
Publicado: (2015)

Krabbe disease: A personal perspective and hypothesis
por: Rafi, Mohammad A.
Publicado: (2022)

Neurodegenerative Disorder Risk in Krabbe Disease Carriers
por: Vantaggiato, Lorenza, et al.
Publicado: (2022)

The Effects of Antipsychotics in Experimental Models of Krabbe Disease
por: Sharma, Kapil, et al.
Publicado: (2023)

Globoid Cell Leukodystrophy (Krabbe Disease): An Update
por: Maghazachi, Azzam A
Publicado: (2023)

Mechanotransduction Impairment in Primary Fibroblast Model of Krabbe Disease
por: Mezzena, Roberta, et al.
Publicado: (2023)

Pathogenic Variants in GALC Gene Correlate With Late Onset Krabbe Disease and Vision Loss: Case Series and Review of Literature
por: Bascou, Nicholas A., et al.
Publicado: (2020)

Optic nerve enlargement in infantile form of Krabbe disease
por: Castilha-Neto, Dimas, et al.
Publicado: (2012)

Adult Krabbe Disease That Was Successfully Treated with Intravenous Immunoglobulin
por: Fukazawa, Ryosuke, et al.
Publicado: (2020)

National U.S. Patient and Transplant Data for Krabbe Disease
por: Ghabash, Gabrielle, et al.
Publicado: (2021)

Identification and Characterization of 15 Novel GALC Gene Mutations Causing Krabbe Disease
por: Tappino, Barbara, et al.
Publicado: (2010)

Array CGH improves detection of mutations in the GALC gene associated with Krabbe disease
por: Tanner, Alice K, et al.
Publicado: (2012)

Conditions for combining gene therapy with bone marrow transplantation in murine Krabbe disease
por: Rafi, Mohammad A., et al.
Publicado: (2020)

Krabbe Disease: Prospects of Finding a Cure Using AAV Gene Therapy
por: Nasir, Gibran, et al.
Publicado: (2021)

Neuron-specific ablation of the Krabbe disease gene galactosylceramidase in mice results in neurodegeneration
por: Kreher, Conlan, et al.
Publicado: (2022)

Chronic lithium administration in a mouse model for Krabbe disease
por: Del Grosso, Ambra, et al.
Publicado: (2021)

Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants
por: Spratley, Samantha J., et al.
Publicado: (2016)

New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones
por: Spratley, Samantha J., et al.
Publicado: (2016)

Serendipitous effects of β-cyclodextrin on murine model of Krabbe disease
por: Katabuchi, Asaka U., et al.
Publicado: (2018)

Report of a Case that Expands the Phenotype of Infantile Krabbe Disease
por: Nashabat, Marwan, et al.
Publicado: (2019)

Genotype and phenotype classification of 29 patients affected by Krabbe disease
por: Madsen, Anna M. H., et al.
Publicado: (2019)

Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease
por: Béchet, Sibylle, et al.
Publicado: (2020)

Krabbe Disease Associated With Mitochondrial Dysfunction in a Chinese Family
por: Wu, Liwen, et al.
Publicado: (2021)

Compound heterozygous pathogenic variants in the GALC gene cause infant-onset Krabbe disease
por: Zhang, Xiaoli, et al.
Publicado: (2021)

The Role of RIPK1 and RIPK3 in Cardiovascular Disease
por: DeRoo, Elise, et al.
Publicado: (2020)

Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy
por: Langan, Thomas J., et al.
Publicado: (2019)

Elevated RIPK3 correlates with disease burden in myelofibrosis
por: Dill, Veronika, et al.
Publicado: (2022)

Psychosine enhances the shedding of membrane microvesicles: Implications in demyelination in Krabbe’s disease
por: D’Auria, Ludovic, et al.
Publicado: (2017)

RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
por: Zelic, Matija, et al.
Publicado: (2021)

Krabbe Disease: Report of a Rare Lipid Storage and Neurodegenerative Disorder
por: Pavuluri, Pratyusha, et al.
Publicado: (2017)

Predominant Corticospinal Tract Involvement in a Late Infant with Krabbe Disease
por: Yoshimura, Ayumi, et al.
Publicado: (2016)

Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease
por: Kwon, Jennifer M., et al.
Publicado: (2018)

Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease
por: Righi, Marco, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_04b7q0bfprs7cpnb9kkqtah6mu